SG69977A1 - Novel 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof - Google Patents

Novel 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof

Info

Publication number
SG69977A1
SG69977A1 SG1996007579A SG1996007579A SG69977A1 SG 69977 A1 SG69977 A1 SG 69977A1 SG 1996007579 A SG1996007579 A SG 1996007579A SG 1996007579 A SG1996007579 A SG 1996007579A SG 69977 A1 SG69977 A1 SG 69977A1
Authority
SG
Singapore
Prior art keywords
compositions
novel
proteolytic enzyme
enzyme inhibitors
aryl carboxylates
Prior art date
Application number
SG1996007579A
Other languages
English (en)
Inventor
Albert Joseph Mura
Chakrapani Subramanyam
Dennis John Hlasta
Manohar Tukram Saindane
Neil Warren Boaz
Ranjit Chimanlal Desai
Richard Paul Dunlap
Virendra Kumar
Original Assignee
Sterling Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Winthrop Inc filed Critical Sterling Winthrop Inc
Publication of SG69977A1 publication Critical patent/SG69977A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539Five-membered rings
    • C07F9/6541Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
SG1996007579A 1990-11-01 1991-10-30 Novel 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof SG69977A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60806890A 1990-11-01 1990-11-01

Publications (1)

Publication Number Publication Date
SG69977A1 true SG69977A1 (en) 2000-01-25

Family

ID=24434891

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996007579A SG69977A1 (en) 1990-11-01 1991-10-30 Novel 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof

Country Status (17)

Country Link
EP (1) EP0483928A1 (fi)
JP (1) JPH04273866A (fi)
KR (1) KR920009807A (fi)
AU (1) AU642537B2 (fi)
CA (1) CA2054653A1 (fi)
FI (1) FI103112B1 (fi)
HU (2) HUT63399A (fi)
IE (1) IE913827A1 (fi)
IL (1) IL99913A (fi)
MX (1) MX9101861A (fi)
MY (1) MY131053A (fi)
NO (1) NO300373B1 (fi)
NZ (1) NZ240444A (fi)
PT (1) PT99411B (fi)
RU (1) RU2114843C1 (fi)
SG (1) SG69977A1 (fi)
TW (1) TW221294B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE159720T1 (de) * 1989-05-04 1997-11-15 Sanofi Sa Saccharinderivate zur verwendung als proteolytische enzyminhibitoren sowie verfahren zur herstellung
US5512589A (en) * 1990-11-01 1996-04-30 Sterling Winthrop Inc. 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5306818A (en) * 1990-11-01 1994-04-26 Sterling Winthrop Inc. Tetrahydro 2-saccharinylmerthyl aryl carboxylates
AU656027B2 (en) * 1991-11-15 1995-01-19 Sanofi Saccharin derivative proteolytic enzime inhibitors
US5378720A (en) * 1991-12-19 1995-01-03 Sterling Winthrop Inc. Saccharin derivative proteolytic enzyme inhibitors
AU668694B2 (en) * 1991-12-19 1996-05-16 Sanofi-Synthelabo Saccharin derivative proteolytic enzyme inhibitors
US5296496A (en) * 1991-12-27 1994-03-22 Sterling Winthrop Inc. 2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5187173A (en) * 1991-12-27 1993-02-16 Sterling Winthrop Inc. 2-saccharinylmethyl and 4,5,6,7-tetrahydro-2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
AU653279B2 (en) * 1991-12-30 1994-09-22 Sanofi Novel 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
TW226016B (fi) * 1991-12-30 1994-07-01 Sterling Winthrop Inc
US5684195A (en) * 1994-07-14 1997-11-04 G. D. Searle & Co. Method of preparing sulfmonamides from sulfones
DE4427996A1 (de) * 1994-08-08 1996-02-15 Basf Ag Verfahren zur Herstellung von Saccharincarbonsäuren und -carbonsäureestern
DE19533643A1 (de) * 1995-09-12 1997-03-13 Nycomed Arzneimittel Gmbh Neue cyclische Derivate von Benzolsulfonamiden
JP6239458B2 (ja) * 2014-07-22 2017-11-29 日本曹達株式会社 2−(ベンジルスルフィニル)−1−シクロアルケン−1−カルボン酸エステルの製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4276298A (en) * 1978-03-24 1981-06-30 Merck & Co., Inc. 2-Aryl-1,2-benzisothiazolinone-1,1-dioxides and their use as selective protease inhibitors
DE3617976A1 (de) * 1986-05-28 1988-01-14 Alter Sa 1,4-dihydropyridin, verfahren zu dessen herstellung und dessen verwendung in antithrombotischen medikamenten
ATE159720T1 (de) * 1989-05-04 1997-11-15 Sanofi Sa Saccharinderivate zur verwendung als proteolytische enzyminhibitoren sowie verfahren zur herstellung

Also Published As

Publication number Publication date
AU642537B2 (en) 1993-10-21
NO914288D0 (no) 1991-11-01
TW221294B (fi) 1994-02-21
HU211929A9 (en) 1996-01-29
FI103112B (fi) 1999-04-30
NZ240444A (en) 1994-06-27
HUT63399A (en) 1993-08-30
NO914288L (no) 1992-05-04
HU913430D0 (en) 1992-01-28
RU2114843C1 (ru) 1998-07-10
CA2054653A1 (en) 1992-05-02
PT99411B (pt) 1999-04-30
FI915163A (fi) 1992-05-02
MX9101861A (es) 1992-07-08
IL99913A (en) 1996-11-14
IE913827A1 (en) 1992-05-22
MY131053A (en) 2007-07-31
IL99913A0 (en) 1992-08-18
KR920009807A (ko) 1992-06-25
EP0483928A1 (en) 1992-05-06
FI915163A0 (fi) 1991-11-01
FI103112B1 (fi) 1999-04-30
AU8608391A (en) 1992-05-07
NO300373B1 (no) 1997-05-20
JPH04273866A (ja) 1992-09-30
PT99411A (pt) 1992-10-30

Similar Documents

Publication Publication Date Title
PH30411A (en) Novel 2-saccharinyl-methyl aryl and aryloxy acetates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
ZA916393B (en) Inhibitors of serine proteases
IL99769A0 (en) Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
EP0519748A3 (en) Peptidyl derivatives as inhibitors of interleukin-1b converting enzyme
MC2313A1 (fr) Inhibiteurs d'enzymes
SG69977A1 (en) Novel 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
PT84338B (pt) Processo de proteccao de uma enzima e de preperecao de composicoes de limpeza
EP0485171A3 (en) Esters and amides of substituted phenyl and pyridyl amino carboxylates
HU9402355D0 (en) Aminoacetyl-mercapto-acetylamide derivatives useful as inhibitors of enkephalinase and ace
PL287114A1 (en) Method of obtaining retroviral proteases inhibitors
AU7780391A (en) Low level blasting composition and method of blasting same
IL111176A0 (en) Dipeptide boronic acid inhibitors of trypsin-like enzymes and pharmaceutical compositions containing them
EP0273689A3 (en) Derivatives of n-(2-alkyl-3-mercapto-glutaryl) alpha-amino acids and their use as collagenase inhibitors
EP0482412A3 (en) Abrasive product and method of its use
PL307854A1 (en) Method of obtaining dust-free enzyme
DE69305411D1 (de) Verfahren zur Beseitigung von Mikroorganismen
ZW7488A1 (en) New method and compositions of matter
DE68927030D1 (de) Verfahren zur Konservierung ophthalmischer Lösungen und Zusammensetzungen dafür
ZA915271B (en) Inhibitors of retroviral proteases
GB9014307D0 (en) Method of treatment and compositions therefor
GB8916886D0 (en) Compositions and methods for removal of detergents
AU7894591A (en) Composition against ozone damages to cultivations and method for its application
ZA915270B (en) Inhibitors of aspartic proteases
IL72487A0 (en) Octahydroindolizinepropanoic acids and related compounds as enzyme inhibitors
GB2239455B (en) Formulations of lipolytic enzyme inhibitors and use of said inhibitors